Literature DB >> 12668868

Autocrine regulation of prolactin secretion by endothelins throughout the estrous cycle.

Béla Kanyicska1, Michael T Sellix, Marc E Freeman.   

Abstract

We have previously found that the ovarian steroid background determines the efficiency of the endothelin-mediated autocrine feedback regulation of prolactin (PRL) secretion. In this study, we investigated the role of endogenous endothelins in regulating PRL secretion during the estrous cycle. Adult female rats representing different stages of the 4-d cycle were sacrificed by decapitation, and the anterior pituitary cells were enzymatically dispersed using collagenase and hyaluronidase. PRL secretion of individual lactotrophs was measured in a PRL-specific reverse hemolytic plaque assay, and the influence of endogenous endothelins on PRL secretion was assessed by applying the selective ET(A) receptor antagonist peptide, BQ123. Blocking the endothelin-mediated autocrine feedback resulted in an increase in PRL secretion when cells were obtained at proestrus, estrus, and diestrus-1, whereas PRL secretion was decreased at diestrus-2 by ET(A) receptor blockade. These observations suggest that endogenous endothelins are predominantly inhibitory during proestrus, estrus, and diestrus-1, whereas at diestrus-2 their influence on PRL secretion is stimulatory. Whereas the bell-shaped concentration-response curves with BQ123 at proestrus and diestrus-1 may indicate a transition state in which endogenous endothelins can be both stimulatory and inhibitory, at estrus the influence of endogenous endothelins is unequivocally inhibitory in nature. We propose that intensification of the endogenous endothelin- mediated negative feedback at estrus may play a role in restraining PRL secretion following the estradiol- induced proestrous PRL surge.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12668868     DOI: 10.1385/ENDO:20:1-2:53

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  34 in total

Review 1.  Hormesis: U-shaped dose responses and their centrality in toxicology.

Authors:  E J Calabrese; L A Baldwin
Journal:  Trends Pharmacol Sci       Date:  2001-06       Impact factor: 14.819

2.  Pituitary lactotrophs: endocrine, paracrine, juxtacrine, and autocrine interactions.

Authors:  N Ben-Jonathan; J W Liu
Journal:  Trends Endocrinol Metab       Date:  1992-09       Impact factor: 12.015

3.  Subpopulations of lactotropes detected with the reverse hemolytic plaque assay show differential responsiveness to dopamine.

Authors:  E H Luque; M Munoz de Toro; P F Smith; J D Neill
Journal:  Endocrinology       Date:  1986-05       Impact factor: 4.736

4.  Autocrine regulation of prolactin secretion by endothelins: a permissive role for estradiol.

Authors:  B Kanyicska; M T Sellix; M E Freeman
Journal:  Endocrine       Date:  2001-11       Impact factor: 3.633

5.  Endothelin-like immunoreactivity in lactotrophs, gonadotrophs, and somatotrophs of rat anterior pituitary gland are affected differentially by ovarian steroid hormones.

Authors:  B Kanyicska; A Lerant; M E Freeman
Journal:  Endocrine       Date:  2001-03       Impact factor: 3.633

6.  Characterization of endothelin receptors in the anterior pituitary gland.

Authors:  B Kanyicska; M E Freeman
Journal:  Am J Physiol       Date:  1993-10

7.  Endothelin is an autocrine regulator of prolactin secretion.

Authors:  B Kanyicska; A Lerant; M E Freeman
Journal:  Endocrinology       Date:  1998-12       Impact factor: 4.736

8.  The endothelin-A receptor subtype transduces the effects of the endothelins in the anterior pituitary gland.

Authors:  W K Samson
Journal:  Biochem Biophys Res Commun       Date:  1992-09-16       Impact factor: 3.575

9.  A reverse hemolytic plaque assay for microscopic visualization of growth hormone release from individual cells: evidence for somatotrope heterogeneity.

Authors:  L S Frawley; J D Neill
Journal:  Neuroendocrinology       Date:  1984-11       Impact factor: 4.914

Review 10.  Neuroendocrine actions of endothelins.

Authors:  S S Stojilković; K J Catt
Journal:  Trends Pharmacol Sci       Date:  1992-10       Impact factor: 14.819

View more
  2 in total

Review 1.  Paracrinicity: the story of 30 years of cellular pituitary crosstalk.

Authors:  C Denef
Journal:  J Neuroendocrinol       Date:  2008-01       Impact factor: 3.627

2.  Improved health-span and lifespan in mtDNA mutator mice treated with the mitochondrially targeted antioxidant SkQ1.

Authors:  Irina G Shabalina; Mikhail Yu Vyssokikh; Natalia Gibanova; Robert I Csikasz; Daniel Edgar; Anne Hallden-Waldemarson; Zinaida Rozhdestvenskaya; Lora E Bakeeva; Valeria B Vays; Antonina V Pustovidko; Maxim V Skulachev; Barbara Cannon; Vladimir P Skulachev; Jan Nedergaard
Journal:  Aging (Albany NY)       Date:  2017-02-15       Impact factor: 5.682

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.